These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10566017)

  • 41. Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections.
    Tabata K; Katashima M; Kawamura A; Kaibara A; Tanigawara Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):324-31. PubMed ID: 16946560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Micafungin: the US perspective.
    Zaas AK; Steinbach WJ
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):183-90. PubMed ID: 15918776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
    Hiemenz J; Cagnoni P; Simpson D; Devine S; Chao N; Keirns J; Lau W; Facklam D; Buell D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1331-6. PubMed ID: 15793107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Echinocandin antifungals: review and update.
    Morrison VA
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choosing a study population for the evaluation of antifungal prophylaxis.
    Cornely OA; Ullmann AJ; Karthaus M
    Clin Infect Dis; 2005 Jun; 40(11):1699; author reply 1699-701. PubMed ID: 15889374
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics/pharmacodynamics of echinocandins.
    Theuretzbacher U
    Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):805-12. PubMed ID: 15490294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
    O'Gorman C; McMullan R; Webb CH; Bedi A
    Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817
    [No Abstract]   [Full Text] [Related]  

  • 48. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anidulafungin: a new echinocandin for the treatment of fungal infections.
    Cohen-Wolkowiez M; Benjamin DK; Steinbach WJ; Smith PB
    Drugs Today (Barc); 2006 Aug; 42(8):533-44. PubMed ID: 16969430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of caspofungin therapy in children with invasive fungal infections.
    Merlin E; Galambrun C; Ribaud P; Blanc T; Michel G; Auvrignon A; Stéphan JL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1186-8. PubMed ID: 17133169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
    Makowsky MJ; Warkentin DI; Savoie ML
    Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined therapies in a murine model of blastoschizomycosis.
    Serena C; Rodríguez MM; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2608-10. PubMed ID: 17452487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Spanakis EK; Aperis G; Mylonakis E
    Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Echinocandins for candidemia in adults without neutropenia.
    Bennett JE
    N Engl J Med; 2006 Sep; 355(11):1154-9. PubMed ID: 16971721
    [No Abstract]   [Full Text] [Related]  

  • 58. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Lyman CA; Walsh TJ
    Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comment: caspofungin acetate for treatment of invasive fungal infections.
    Chan J
    Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
    [No Abstract]   [Full Text] [Related]  

  • 60. Micafungin in pediatrics: when one size does not fit all.
    Ashouri N; Singh J; Arrieta A
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):463-9. PubMed ID: 18433348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.